NMS·Healthcare·$2.4B·#402 / 520 in Healthcare
GRAL GRAIL, Inc.
28HIGH RISK
CATEGORY BREAKDOWN
GROWTH27
QUALITY0
STABILITY53
VALUATION24
GOVERNANCE28
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+17.2%
27
> 50% strong
Gross Margin
Revenue retained after direct costs
-42.5%
0
> 50% strong
Cash Runway
Months of cash at current burn rate
10 months
30
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
2.1%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
16.0x
24
< 3x strong
Rule of 40
Growth rate plus operating margin
-346
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.7%
38
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+21.6%
8
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE GRAL WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when GRAL's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.